Aagya Biotech

Aagya Biotech, established in 2017, is a WHO-GMP and ISO 9001:2015 certified pharmaceutical finished dosage formulation manufacturer and exporter based in Uttarakhand, India. As part of the GS Pharmaceuticals group (founded 1979), the company operates state-of-the-art facilities adhering to stringent international quality standards. This foundation supports its role in the pharmaceutical and healthcare sectors.

The manufacturing complex includes Unit-I for general formulations (Solid Oral, Semi-Solid, Liquid Dosage Forms), Unit-II for Beta-Lactam formulations (Tablets, Capsules, Dry Syrups), and Unit-III for additional general formulations. Employing 500 - 1,000 individuals across its single location, Aagya Biotech is also a key supplier and trader of high-quality Active Pharmaceutical Ingredients (APIs), serving as a preferred partner for pharmaceutical companies. Meet Aagya Biotech's team to learn about the professionals behind these operations.

Generating $50.2M in revenue, Aagya Biotech operates on a business-to-business (B2B) model, supplying essential pharmaceutical products and APIs globally. Its strategic Indian base, certifications, and broad product portfolio enable effective market penetration. The company's integration within the experienced GS Pharmaceuticals group provides a robust platform for continued growth and expansion in the competitive pharmaceutical industry.